RiverPark Advisors LLC Purchases 180 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

RiverPark Advisors LLC lifted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 2.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 7,051 shares of the healthcare conglomerate’s stock after purchasing an additional 180 shares during the period. UnitedHealth Group accounts for approximately 2.5% of RiverPark Advisors LLC’s portfolio, making the stock its 13th biggest holding. RiverPark Advisors LLC’s holdings in UnitedHealth Group were worth $3,570,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in UNH. Geode Capital Management LLC raised its stake in UnitedHealth Group by 1.6% during the 4th quarter. Geode Capital Management LLC now owns 19,956,219 shares of the healthcare conglomerate’s stock valued at $10,068,869,000 after purchasing an additional 319,515 shares during the last quarter. Capital International Investors raised its position in shares of UnitedHealth Group by 6.2% during the fourth quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate’s stock valued at $7,899,905,000 after buying an additional 906,365 shares during the last quarter. Norges Bank acquired a new stake in UnitedHealth Group during the fourth quarter worth about $6,375,744,000. Franklin Resources Inc. raised its holdings in UnitedHealth Group by 10.7% in the 4th quarter. Franklin Resources Inc. now owns 8,923,770 shares of the healthcare conglomerate’s stock valued at $4,514,178,000 after acquiring an additional 861,854 shares in the last quarter. Finally, Bank of New York Mellon Corp grew its holdings in shares of UnitedHealth Group by 0.5% during the 4th quarter. Bank of New York Mellon Corp now owns 7,931,478 shares of the healthcare conglomerate’s stock worth $4,012,218,000 after purchasing an additional 36,394 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 0.3 %

Shares of NYSE:UNH opened at $428.25 on Thursday. The stock’s fifty day moving average price is $506.92 and its 200-day moving average price is $537.23. The company has a market cap of $391.73 billion, a P/E ratio of 27.63, a PEG ratio of 1.37 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1 year low of $417.12 and a 1 year high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). The company had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same period last year, the company earned $6.91 EPS. Sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were paid a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.96%. UnitedHealth Group’s payout ratio is 35.18%.

Wall Street Analysts Forecast Growth

UNH has been the topic of several analyst reports. Barclays lowered their price target on shares of UnitedHealth Group from $642.00 to $560.00 and set an “overweight” rating on the stock in a report on Monday. Truist Financial cut their price target on shares of UnitedHealth Group from $660.00 to $580.00 and set a “buy” rating for the company in a research note on Monday. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. Royal Bank of Canada dropped their price objective on UnitedHealth Group from $655.00 to $525.00 and set an “outperform” rating for the company in a research note on Wednesday. Finally, Argus lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Monday. Three investment analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and three have issued a strong buy rating to the stock. According to MarketBeat, UnitedHealth Group currently has an average rating of “Buy” and a consensus price target of $604.67.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.